–
Zenas BioPharma, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−37.1
FY24:
−164
FY25:
−383
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
−163
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−119
FY23:
−36.8
FY24:
−157
FY25:
−378
(positive)
Change from FY22 to FY25
millions USD
FY22:
−119
FY23:
−37.1
FY24:
−157
FY25:
−378
All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.